To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma
Latest Information Update: 12 Sep 2024
At a glance
- Drugs Naxitamab (Primary)
- Indications Ewing's sarcoma
- Focus Adverse reactions
Most Recent Events
- 11 Apr 2023 New trial record